ETROLIZUMAB INDUCTION THERAPY IMPROVED ENDOSCOPIC SCORE, PATIENT-REPORTED OUTCOMES, AND INFLAMMATORY BIOMARKERS IN PATIENTS WITH MODERATE TO SEVERE UC WHO HAD FAILED TNF ANTAGONIST THERAPY: RESULTS FROM THE HICKORY OPEN-LABEL INDUCTION (OLI) TRIAL

Laurent Peyrin-Biroulet  1     David T. Rubin  2     Brian G. Feagan  3     Young S. Oh  4     Udaysankar Arulmani  4     Helen Tyrrell  5     Romeo Maciuca     Sarah Williams     Swati Tole     James Thommes    
1 UniversitĂ© de Lorraine,Vandoeuvre-lès-Nancy,France
2 University of Chicago Medicine,Inflammatory Bowel Disease Center,Chicago,United States of America
3 University of Western Ontario,London,Canada
4 Genentech, Inc.,South San Francisco,United States of America
5 Roche Products L

Conference
25th UEG Week 2017

Citation
United European Gastroenterology Journal 2017; 5 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing